{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:36Z","timestamp":1761901656037,"version":"build-2065373602"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014981","name":"Biological Anthropology Section","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010413","name":"Fundaci\u00f3n Ren\u00e9 Bar\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010413","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.msard.2021.102845","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T13:28:03Z","timestamp":1613568483000},"page":"102845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Insights into the role of B cells in the cortical pathology of Multiple sclerosis:\u00a0evidence from animal models and patients"],"prefix":"10.1016","volume":"50","author":[{"given":"Berenice Anabel","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Miglietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina Cintia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.msard.2021.102845_bib0001","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0000000000003820","article-title":"Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases","volume":"88","author":"Absinta","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","article-title":"Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis","volume":"85","author":"Absinta","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-5728(99)00225-8","article-title":"Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis","volume":"104","author":"Alcazar","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.msard.2021.102845_bib0004","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ni0509-453","article-title":"Gaining entry to an uninflamed brain","volume":"10","author":"Axtell","year":"2009","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0006","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/j.msard.2021.102845_bib0007","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1001431","article-title":"TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica","volume":"185","author":"Barr","year":"2010","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.msard.2021.102845_bib0008","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med"},{"issue":"7269","key":"10.1016\/j.msard.2021.102845_bib0009","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature08478","article-title":"Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions","volume":"462","author":"Bartholomaus","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.msard.2021.102845_bib0010","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A5534","article-title":"Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE","author":"Beck","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0011","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.25365","article-title":"Meningeal inflammation and cortical demyelination in acute multiple sclerosis","volume":"84","author":"Bevan","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2021.102845_bib0012","doi-asserted-by":"crossref","first-page":"34594","DOI":"10.1038\/srep34594","article-title":"B cell-derived transforming growth factor-beta1 expression limits the induction phase of autoimmune neuroinflammation","volume":"6","author":"Bjarnadottir","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0013","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0014","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-015-1500-6","article-title":"Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants","volume":"130","author":"Blauth","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0015","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1038\/s41598-020-61928-w","article-title":"Novel B cell-dependent multiple sclerosis model using extracellular domains of myelin proteolipid protein","volume":"10","author":"Boyden","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0016","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/brain\/aww296","article-title":"An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis","volume":"140","author":"Brown","year":"2017","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.nic.2016.12.009","article-title":"Cortical Gray Matter MR Imaging in Multiple Sclerosis","volume":"27","author":"Calabrese","year":"2017","journal-title":"Neuroimaging clinics of North America"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/pri.22580","article-title":"Grey matter lesions in MS: from histology to clinical implications","volume":"7","author":"Calabrese","year":"2013","journal-title":"Prion"},{"issue":"Pt 10","key":"10.1016\/j.msard.2021.102845_bib0019","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/brain\/aws246","article-title":"Cortical lesion load associates with progression of disability in multiple sclerosis","volume":"135","author":"Calabrese","year":"2012","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.msard.2021.102845_bib0020","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3174\/ajnr.A3011","article-title":"Gray matter pathology in MS: a 3-year longitudinal study in a pediatric population","volume":"33","author":"Calabrese","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.msard.2021.102845_bib0021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/14728214.2020.1822817","article-title":"Bruton's tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis","volume":"25","author":"Carnero Contentti","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"issue":"7","key":"10.1016\/j.msard.2021.102845_bib0022","doi-asserted-by":"crossref","first-page":"e66308","DOI":"10.1371\/journal.pone.0066308","article-title":"Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review","volume":"8","author":"Castillo-Trivino","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.msard.2021.102845_bib0023","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/imm.12808","article-title":"Programmed death 1 is highly expressed on CD8(+) CD57(+) T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus","volume":"152","author":"Cencioni","year":"2017","journal-title":"Immunology"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102845_bib0024","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2006.06.015","article-title":"Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein","volume":"179","author":"Columba-Cabezas","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.msard.2021.102845_bib0025","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.msard.2021.102845_bib0026","first-page":"430","article-title":"Ectopic Lymphoid Structures: Powerhouse of","volume":"7","author":"Corsiero","year":"2016","journal-title":"Autoimmunity. Front Immunol"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0027","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood-2002-06-1761","article-title":"Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts","volume":"101","author":"Cragg","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.msard.2021.102845_bib0028","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.4049\/jimmunol.1600782","article-title":"CD40-Mediated NF-kappaB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics","volume":"197","author":"Chen","year":"2016","journal-title":"J Immunol"},{"issue":"Pt 10","key":"10.1016\/j.msard.2021.102845_bib0029","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12974-019-1501-9","article-title":"Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis","volume":"16","author":"DiSano","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.msard.2021.102845_bib0031","first-page":"1821","article-title":"Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of","volume":"10","author":"DiSano","year":"2019","journal-title":"Progressive Multiple Sclerosis. Front Immunol"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0032","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.1701484","article-title":"GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction","volume":"200","author":"Duncker","year":"2018","journal-title":"J Immunol"},{"issue":"22 Suppl 3","key":"10.1016\/j.msard.2021.102845_bib0033","first-page":"S22","article-title":"Pathogenesis of axonal and neuronal damage in multiple sclerosis","volume":"68","author":"Dutta","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0034","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ana.25429","article-title":"A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis","volume":"85","author":"Fadda","year":"2019","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.msard.2021.102845_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127805","article-title":"The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset","volume":"10","author":"Favaretto","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.msard.2021.102845_bib0036","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"issue":"Pt 6","key":"10.1016\/j.msard.2021.102845_bib0037","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/brain\/awt110","article-title":"Disease-specific molecular events in cortical multiple sclerosis lesions","volume":"136","author":"Fischer","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.102845_bib0038","article-title":"A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis","author":"Fox","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2021.102845_bib0039","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clim.2016.10.001","article-title":"B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses","volume":"173","author":"Fraussen","year":"2016","journal-title":"Clin Immunol"},{"issue":"Pt 12","key":"10.1016\/j.msard.2021.102845_bib0040","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1093\/brain\/awt279","article-title":"Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats","volume":"136","author":"Gardner","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0041","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.msard.2021.102845_bib0042","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1172\/JCI119455","article-title":"Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy","volume":"99","author":"Genc","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020448","article-title":"Facets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An Update","volume":"20","author":"Gerhauser","year":"2019","journal-title":"International journal of molecular sciences"},{"key":"10.1016\/j.msard.2021.102845_bib0044","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.imlet.2019.09.003","article-title":"IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression","volume":"216","author":"Gharibi","year":"2019","journal-title":"Immunol Lett"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102845_bib0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2015.10.012","article-title":"The effect of B-cell depletion in the Theiler's model of multiple sclerosis","volume":"359","author":"Gilli","year":"2015","journal-title":"J Neurol Sci"},{"issue":"Pt 3","key":"10.1016\/j.msard.2021.102845_bib0046","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/awv398","article-title":"The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain","volume":"139","author":"Haider","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0047","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clim.2008.05.002","article-title":"Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis","volume":"128","author":"Harp","year":"2008","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0048","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa1917246","article-title":"Ofatumumab versus Teriflunomide in Multiple Sclerosis","volume":"383","author":"Hauser","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0049","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.msard.2021.102845_bib0050","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.msard.2021.102845_bib0051","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"Hawker","year":"2009","journal-title":"Ann Neurol"},{"issue":"Pt 9","key":"10.1016\/j.msard.2021.102845_bib0052","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.msard.2021.102845_bib0053","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/08916934.2012.665529","article-title":"Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity","volume":"45","author":"Ireland","year":"2012","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.msard.2021.102845_bib0054","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/NEN.0b013e3182622691","article-title":"B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model","volume":"71","author":"Jagessar","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40478-020-00938-1","article-title":"Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration","volume":"8","author":"James","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.msard.2021.102845_bib0057","article-title":"Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis","author":"Jonkman","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2021.102845_bib0058","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3389\/fimmu.2020.01051","article-title":"Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis","volume":"11","author":"Kang","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.msard.2021.102845_bib0059","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.4049\/jimmunol.1001393","article-title":"Late B cell depletion with a human anti-human CD20 IgG1kappa monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets","volume":"185","author":"Kap","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bpa.12454","article-title":"Multiple sclerosis animal models: a clinical and histopathological perspective","volume":"27","author":"Kipp","year":"2017","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.msard.2021.102845_bib0061","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/NEN.0000000000000189","article-title":"Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis","volume":"74","author":"Klaver","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0062","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4161\/mabs.22771","article-title":"Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties","volume":"5","author":"Klein","year":"2013","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0063","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.24408","article-title":"Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis","volume":"78","author":"Komori","year":"2015","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0064","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/bpa.12180","article-title":"Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis","volume":"25","author":"Kramann","year":"2015","journal-title":"Brain Pathol"},{"issue":"11","key":"10.1016\/j.msard.2021.102845_bib0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","article-title":"B cells and antibodies in multiple sclerosis pathogenesis and therapy","volume":"8","author":"Krumbholz","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aanat.2007.11.001","article-title":"Comparing the CNS morphology and immunobiology of different EAE models in C57BL\/6 mice - a step towards understanding the complexity of multiple sclerosis","volume":"190","author":"Kuerten","year":"2008","journal-title":"Annals of anatomy\u00a0=\u00a0Anatomischer Anzeiger: official organ of the Anatomische Gesellschaft"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0067","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.clim.2008.07.016","article-title":"Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis","volume":"129","author":"Kuerten","year":"2008","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.msard.2021.102845_bib0068","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.4049\/jimmunol.180.7.4763","article-title":"TLR-activated B cells suppress T cell-mediated autoimmunity","volume":"180","author":"Lampropoulou","year":"2008","journal-title":"J Immunol"},{"issue":"Pt 10","key":"10.1016\/j.msard.2021.102845_bib0069","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1093\/brain\/aws260","article-title":"Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration","volume":"135","author":"Lassmann","year":"2012","journal-title":"Brain"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102845_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.05.010","article-title":"Pathology and disease mechanisms in different stages of multiple sclerosis","volume":"333","author":"Lassmann","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.msard.2021.102845_bib0071","doi-asserted-by":"crossref","DOI":"10.1097\/WCO.0000000000000685","article-title":"The changing concepts in the neuropathology of acquired demyelinating central nervous system disorders","author":"Lassmann","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.msard.2021.102845_bib0072","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.msard.2021.102845_bib0073","first-page":"626","article-title":"Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis","volume":"6","author":"Li","year":"2015","journal-title":"Front Immunol"},{"issue":"310","key":"10.1016\/j.msard.2021.102845_bib0074","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Science translational medicine"},{"key":"10.1016\/j.msard.2021.102845_bib0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2018.03.062","article-title":"The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review","volume":"151","author":"Liang","year":"2018","journal-title":"European journal of medicinal chemistry"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102845_bib0076","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro","volume":"246","author":"Lisak","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.msard.2021.102845_bib0077","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2017.05.004","article-title":"B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro","volume":"309","author":"Lisak","year":"2017","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0078","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0079","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1016\/j.msard.2021.102845_bib0080","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102845_bib0081","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2003.10.056","article-title":"Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis","volume":"148","author":"Magliozzi","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"11","key":"10.1016\/j.msard.2021.102845_bib0082","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/acn3.50893","article-title":"Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis","volume":"6","author":"Magliozzi","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"Pt 4","key":"10.1016\/j.msard.2021.102845_bib0083","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.102845_bib0084","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25197","article-title":"Inflammatory intrathecal profiles and cortical damage in multiple sclerosis","author":"Magliozzi","year":"2018","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.msard.2021.102845_bib0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2021.102845_bib0086","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25786","article-title":"The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity","author":"Magliozzi","year":"2020","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0087","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/NEN.0b013e31827bfc62","article-title":"B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis","volume":"72","author":"Magliozzi","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 4","key":"10.1016\/j.msard.2021.102845_bib0088","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/brain\/awv011","article-title":"A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging","volume":"138","author":"Mainero","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.102845_bib0089","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8652463","article-title":"Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis","volume":"2017","author":"Makshakov","year":"2017","journal-title":"Neurol Res Int"},{"issue":"10","key":"10.1016\/j.msard.2021.102845_bib0090","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.msard.2021.102845_bib0091","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1084\/jem.194.7.873","article-title":"Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis","volume":"194","author":"McQualter","year":"2001","journal-title":"J Exp Med"},{"issue":"Pt 8","key":"10.1016\/j.msard.2021.102845_bib0092","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/brain\/awl135","article-title":"A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination","volume":"129","author":"Merkler","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.102845_bib0093","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2015.00636","article-title":"B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation","volume":"6","author":"Michel","year":"2015","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.msard.2021.102845_bib0094","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.msard.2021.102845_bib0096","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/1352458511405561","article-title":"Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis","volume":"17","author":"Nelson","year":"2011","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.msard.2021.102845_bib0097","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3174\/ajnr.A0645","article-title":"Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging","volume":"28","author":"Nelson","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0098","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.171.1.462","article-title":"Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL\/6 mice","volume":"171","author":"Oliver","year":"2003","journal-title":"J Immunol"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102845_bib0099","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2010.09.026","article-title":"Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis","volume":"232","author":"Pachner","year":"2011","journal-title":"J Neuroimmunol"},{"issue":"Pt 5","key":"10.1016\/j.msard.2021.102845_bib0100","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/brain\/awp296","article-title":"Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"133","author":"Peferoen","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.102845_bib0101","article-title":"Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice","volume":"335","author":"Pol","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.msard.2021.102845_bib0102","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2019.01.013","article-title":"Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis","volume":"314","author":"Pol","year":"2019","journal-title":"Exp Neurol"},{"issue":"Pt 11","key":"10.1016\/j.msard.2021.102845_bib0103","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/brain\/awh626","article-title":"Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis","volume":"128","author":"Pomeroy","year":"2005","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.410100205","article-title":"Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown","volume":"10","author":"Prineas","year":"1981","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/ane.12915","article-title":"B cells in multiple sclerosis therapy-A comprehensive review","volume":"137","author":"Rahmanzadeh","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"7269","key":"10.1016\/j.msard.2021.102845_bib0106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/462041a","article-title":"Immunology: In the beginning","volume":"462","author":"Ransohoff","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.msard.2021.102845_bib0107","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","article-title":"C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.msard.2021.102845_bib0108","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0109","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1352458509102907","article-title":"Accumulation of cortical lesions in MS: relation with cognitive impairment","volume":"15","author":"Roosendaal","year":"2009","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.msard.2021.102845_bib0110","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/nm.3680","article-title":"Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production","volume":"20","author":"Rosser","year":"2014","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0111","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.trsl.2014.08.005","article-title":"The meninges: new therapeutic targets for multiple sclerosis","volume":"165","author":"Russi","year":"2015","journal-title":"Translational research: the journal of laboratory and clinical medicine"},{"issue":"14","key":"10.1016\/j.msard.2021.102845_bib0112","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","article-title":"Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis","volume":"74","author":"Sargsyan","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjh.14534","article-title":"A phase 1\/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab","volume":"177","author":"Sawas","year":"2017","journal-title":"British journal of haematology"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0114","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40263-020-00704-w","article-title":"Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis","volume":"34","author":"Sellebjerg","year":"2020","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.msard.2021.102845_bib0115","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0116","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"issue":"7","key":"10.1016\/j.msard.2021.102845_bib0117","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","article-title":"Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation","volume":"69","author":"Serafini","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"10.1016\/j.msard.2021.102845_bib0118","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/jnnp-2012-303023","article-title":"Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI","volume":"83","author":"Sethi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2021.102845_bib0119","article-title":"Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target?","author":"Silva","year":"2018","journal-title":"Reviews in the neurosciences"},{"key":"10.1016\/j.msard.2021.102845_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2018.01.010","article-title":"A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: Influence of innate immunity","author":"Silva","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.msard.2021.102845_bib0121","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2018.00554","article-title":"Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-MS Subjects","volume":"9","author":"Stein","year":"2018","journal-title":"Frontiers in neurology"},{"key":"10.1016\/j.msard.2021.102845_bib0122","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fimmu.2017.00804","article-title":"A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model","volume":"8","author":"t Hart","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.msard.2021.102845_bib0123","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.coi.2019.07.007","article-title":"Understanding regulatory B cells in autoimmune diseases: the case of multiple sclerosis","volume":"61","author":"Thi Cuc","year":"2019","journal-title":"Current opinion in immunology"},{"issue":"4","key":"10.1016\/j.msard.2021.102845_bib0124","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1750-3639.2009.00343.x","article-title":"Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients","volume":"20","author":"Torkildsen","year":"2010","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","article-title":"Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients","volume":"134","author":"van Nierop","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"Pt 8","key":"10.1016\/j.msard.2021.102845_bib0126","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/brain\/awu139","article-title":"Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics","volume":"137","author":"Vidaurre","year":"2014","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2021.102845_bib0127","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.24190","article-title":"Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis","volume":"76","author":"Villar","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI22833","article-title":"Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS","volume":"115","author":"Villar","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0129","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awy301","article-title":"Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis","volume":"142","author":"von Essen","year":"2019","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2021.102845_bib0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.msard.2021.102845_bib0131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann Neurol"},{"issue":"Pt 12","key":"10.1016\/j.msard.2021.102845_bib0132","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2021.102845_bib0133","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-009-0627-8","article-title":"Choroid plexus: biology and pathology","volume":"119","author":"Wolburg","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.msard.2021.102845_bib0134","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/1352458516678083","article-title":"Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study","volume":"23","author":"Zivadinov","year":"2017","journal-title":"Mult Scler"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:52:40Z","timestamp":1761900760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":134,"alternative-id":["S2211034821001115"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102845","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the role of B cells in the cortical pathology of Multiple sclerosis:\u00a0evidence from animal models and patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102845"}}